Annual Retained Earnings
-$181.84 M
-$66.39 M-57.51%
December 31, 2023
Summary
- As of February 8, 2025, LXEO annual retained earnings is -$181.84 million, with the most recent change of -$66.39 million (-57.51%) on December 31, 2023.
- During the last 3 years, LXEO annual retained earnings has fallen by -$176.29 million (-3177.70%).
- LXEO annual retained earnings is now -3177.70% below its all-time high of -$5.55 million, reached on December 1, 2020.
Performance
LXEO Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$254.25 M
-$29.49 M-13.12%
September 30, 2024
Summary
- As of February 8, 2025, LXEO quarterly retained earnings is -$254.25 million, with the most recent change of -$29.49 million (-13.12%) on September 30, 2024.
- Over the past year, LXEO quarterly retained earnings has dropped by -$86.60 million (-51.65%).
- LXEO quarterly retained earnings is now -120.23% below its all-time high of -$115.45 million, reached on December 31, 2022.
Performance
LXEO Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
LXEO Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -57.5% | -51.6% |
| 3 y3 years | -3177.7% | -51.6% |
| 5 y5 years | -3177.7% | -51.6% |
LXEO Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -223.7% | at low | -120.2% | at low |
| 5 y | 5-year | -3177.7% | at low | -120.2% | at low |
| alltime | all time | -3177.7% | at low | -120.2% | at low |
Lexeo Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$254.25 M(+13.1%) |
| Jun 2024 | - | -$224.76 M(+10.4%) |
| Mar 2024 | - | -$203.52 M(+11.9%) |
| Dec 2023 | -$181.84 M | -$181.84 M(+8.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | -$167.65 M(+13.6%) |
| Jun 2023 | - | -$147.54 M(+27.8%) |
| Dec 2022 | -$115.45 M(+105.5%) | -$115.45 M |
| Dec 2021 | -$56.17 M(+912.5%) | - |
| Dec 2020 | -$5.55 M | - |
FAQ
- What is Lexeo Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Lexeo Therapeutics?
- What is Lexeo Therapeutics annual retained earnings year-on-year change?
- What is Lexeo Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Lexeo Therapeutics?
- What is Lexeo Therapeutics quarterly retained earnings year-on-year change?
What is Lexeo Therapeutics annual retained earnings?
The current annual retained earnings of LXEO is -$181.84 M
What is the all time high annual retained earnings for Lexeo Therapeutics?
Lexeo Therapeutics all-time high annual retained earnings is -$5.55 M
What is Lexeo Therapeutics annual retained earnings year-on-year change?
Over the past year, LXEO annual retained earnings has changed by -$66.39 M (-57.51%)
What is Lexeo Therapeutics quarterly retained earnings?
The current quarterly retained earnings of LXEO is -$254.25 M
What is the all time high quarterly retained earnings for Lexeo Therapeutics?
Lexeo Therapeutics all-time high quarterly retained earnings is -$115.45 M
What is Lexeo Therapeutics quarterly retained earnings year-on-year change?
Over the past year, LXEO quarterly retained earnings has changed by -$86.60 M (-51.65%)